Navigation Links
Insmed to Host First Quarter 2009 Conference Call
Date:4/23/2009

ase, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of product candidates, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our continuing efforts to develop IPLEX(TM) may be unsuccessful our common stock could be delisted from the Nasdaq Capital Market and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2008. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

    Investor Relations Contact:
    Brian Ritchie - FD
    212-850-5683
    brian.ritchie@fd.com

    Media Contact:
    Irma Gomez-Dib - FD
    212-850-5761
    Irma.gomez-dib@fd.com


'/>"/>
SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
2. Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
3. Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
4. Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call
5. Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
6. Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference
7. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008
8. NASDAQs Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmeds Compliance Date to March 20, 2009
9. Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule
10. Insmed to Seek Shareholder Approval for Reverse Split
11. Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a project managed ... legal requirements around using controlled substances in pharmaceutical research, ... their international operations expand and become increasingly complex, large ... a result of the first phase of the CSCS ...
(Date:1/22/2015)... Diagenode, Inc., a leading global provider ... complete solutions for epigenetics research, recently launched a ... need for manual processing. The new ChIPettor System ... histones or transcription factors and a semi-automated pipette ...
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:1/22/2015)... 2015   GenoSpace , a precision medicine software company that ... broad use of genomic, imaging and other biomedical data in ... Michelle Munson , CEO of Aspera, an IBM Company, to ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to ...
Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4GenoSpace Expands Board with Appointment of Michelle Munson 2
... Report the Use of Haptoglobin Typing,to Predict Cardiovascular ... MONTVALE, N.J., Nov. 10 Synvista,Therapeutics, Inc. ... Annual Scientific,Sessions of the American Heart Association, underway ... determine haptoglobin (Hp) genotype utilizing,intellectual property licensed from ...
... Nov. 10 SenesTech, Inc. has launched,the regulatory ... the first,ContraPest(R) product with the government of Australia. ... rice field rat species, registration,of ContraPest(R) bait will ... management product to the agricultural ministries of Southeast,Asia. ...
... with more than $500 million in ... cash - Conference ... ... ISIS ) today announced its financial results,for the third quarter ended September 30, 2008. Isis, ...
Cached Biology Technology:Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 2Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 3Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 4Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 5SenesTech, Inc. Commences Product Registration Process With Australian Government 2Isis Reports Financial Results and Highlights for Third Quarter of 2008 2Isis Reports Financial Results and Highlights for Third Quarter of 2008 3Isis Reports Financial Results and Highlights for Third Quarter of 2008 4Isis Reports Financial Results and Highlights for Third Quarter of 2008 5Isis Reports Financial Results and Highlights for Third Quarter of 2008 6Isis Reports Financial Results and Highlights for Third Quarter of 2008 7Isis Reports Financial Results and Highlights for Third Quarter of 2008 8Isis Reports Financial Results and Highlights for Third Quarter of 2008 9Isis Reports Financial Results and Highlights for Third Quarter of 2008 10Isis Reports Financial Results and Highlights for Third Quarter of 2008 11Isis Reports Financial Results and Highlights for Third Quarter of 2008 12Isis Reports Financial Results and Highlights for Third Quarter of 2008 13Isis Reports Financial Results and Highlights for Third Quarter of 2008 14Isis Reports Financial Results and Highlights for Third Quarter of 2008 15
(Date:12/17/2014)... Va. , Dec. 15, 2014 The Defense ... easier to detect and prevent counterfeit microcircuits from entering ... started performing an in-house microcircuit anti-counterfeit initiative dubbed DNA ... microcircuits while increasing their reliability throughout the supply chain. ...
(Date:12/15/2014)... and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) has announced ... 2015-2019" report to their offering. ... a technology used for the identification of individuals. Facial ... person such as nose, jaw edges, mouth, and the ...
(Date:12/10/2014)... YORK , Dec. 8, 2014 You,ve been here before: ... can,t remember your password, site key or the answer to your ... teacher? Today, Hoyos Labs , a digital ... put an end to the frustration that comes with usernames, passwords ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... Francisco, and collaborators at Harvard Medical School have linked ... that clears glucose out of the bloodstream, shedding light ... a cellular level. Establishing the function ... mice, has broad implications for both the future study ...
... Secretary Steve Chu are consistent in their message that ... an alternative to gasoline are coming. While the focus ... on global warming, such a shift could also impact ... (EBI) has produced a novel and comprehensive "Life Cycle ...
... cherry juice could help ease the pain for people who ... University presented at the American College of Sports Medicine Conference ... tart cherry juice while training for a long distance run ... Post-exercise pain can often indicate muscle damage or debilitating ...
Cached Biology News:UCSF discovers new glucose-regulating protein linked with diabetes 2The coming of biofuels: Study shows reducing gasoline emissions will benefit human health 2The coming of biofuels: Study shows reducing gasoline emissions will benefit human health 3The coming of biofuels: Study shows reducing gasoline emissions will benefit human health 4Is cherry juice a new 'sports drink?' 2
actin from rabbit muscle Cell Biology Cytoskeletal Probes Actin and Actin Probes...
... ES1301 mutS are mismatch repair minus strains ... prevents repair of the newly synthesized unmethylated ... and making them helpful in such systems ... Mutagenesis Systems. Both ES1301 and BMH 71-18 ...
propidium iodide *1.0 mg/mL solution in water*...
Applications: (+) Immunocytochemistry and immunohistochemistry...
Biology Products: